122 participants
Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-10-12
- Start Date:
- 2021-09-07
- Completion:
- 2029-12-31
Conditions
- Progression-free Survival
- Gastrointestinal Stromal Tumor
- Neoadjuvant
Interventions
- DRUG
No Results Yet